US Stock MarketDetailed Quotes

TARA Protara Therapeutics

Watchlist
  • 3.370
  • -0.020-0.59%
Close May 6 16:00 ET
  • 3.490
  • +0.120+3.56%
Pre 08:00 ET
130.01MMarket Cap-1.55P/E (TTM)

Protara Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
4.66%-35.81M
-6.99%-9.31M
-28.55%-8.43M
18.29%-7.69M
19.47%-10.38M
-41.95%-37.56M
-73.10%-8.7M
-22.70%-6.56M
-83.64%-9.41M
-17.58%-12.89M
Net income from continuing operations
-10.33%-44.6M
-24.93%-12.77M
-13.78%-11.22M
15.77%-9.51M
-22.66%-11.1M
38.71%-40.42M
73.77%-10.22M
-28.20%-9.86M
-32.26%-11.29M
15.90%-9.05M
Depreciation and amortization
-2.64%332K
-23.36%82K
6.33%84K
6.41%83K
7.79%83K
37.50%341K
42.67%107K
23.44%79K
47.17%78K
37.50%77K
Other non cash items
-0.39%1.01M
-14.24%259K
807.14%254K
-26.90%250K
-27.86%246K
-25.84%1.01M
-11.70%302K
-91.79%28K
0.00%342K
0.00%341K
Change In working capital
196.81%4.01M
1,199.12%2.5M
-1.34%1.85M
2,394.74%436K
86.63%-771K
-867.90%-4.14M
-109.19%-227K
717.47%1.87M
-102.59%-19K
-99.34%-5.77M
-Change in prepaid assets
199.76%1.26M
163.00%1.72M
-860.00%-950K
-98.61%57K
107.08%435K
-577.36%-1.27M
-6.30%654K
-55.83%125K
772.55%4.1M
-418.13%-6.15M
-Change in payables and accrued expense
1,082.80%4.06M
358.16%1.66M
61.56%2.95M
107.50%112K
-201.68%-665K
-75.13%343K
-131.96%-643K
808.46%1.83M
-341.75%-1.49M
145.04%654K
-Change in other current assets
85.74%-328K
-20,966.67%-632K
258.33%95K
122.22%510K
-618.97%-301K
-1,136.04%-2.3M
-103.30%-3K
-177.92%-60K
-9,462.50%-2.3M
-25.64%58K
-Change in other current liabilities
-7.31%-984K
-7.66%-253K
-1,205.26%-248K
26.59%-243K
27.71%-240K
30.90%-917K
29.22%-235K
94.28%-19K
0.00%-331K
0.00%-332K
Cash from discontinued investing activities
Operating cash flow
4.66%-35.81M
-6.99%-9.31M
-28.55%-8.43M
18.29%-7.69M
19.47%-10.38M
-41.95%-37.56M
-73.10%-8.7M
-22.70%-6.56M
-83.64%-9.41M
-17.58%-12.89M
Investing cash flow
Cash flow from continuing investing activities
-63.93%19.16M
54.98%22.5M
-560.80%-29.39M
-86.82%2.95M
134.28%23.1M
255.23%53.11M
179.14%14.52M
-66.52%6.38M
65.54%22.35M
1,223.49%9.86M
Net PPE purchase and sale
-40.00%-63K
--0
78.38%-8K
-2,650.00%-55K
--0
62.50%-45K
--0
55.42%-37K
90.00%-2K
45.45%-6K
Net investment purchase and sale
-63.84%19.22M
54.98%22.5M
-558.02%-29.38M
-86.58%3M
134.14%23.1M
252.70%53.15M
179.16%14.52M
-66.47%6.42M
65.31%22.35M
1,205.03%9.87M
Cash from discontinued investing activities
Investing cash flow
-63.93%19.16M
54.98%22.5M
-560.80%-29.39M
-86.82%2.95M
134.28%23.1M
255.23%53.11M
179.14%14.52M
-66.52%6.38M
65.54%22.35M
1,223.49%9.86M
Financing cash flow
Cash flow from continuing financing activities
153,797.80%139.87M
97.85M
0
42.09M
-18.75%-76K
-1.11%-91K
0
-50.00%-27K
0
11.11%-64K
Net common stock issuance
--136.01M
--94.04M
--0
65,587.50%42.04M
-18.75%-76K
--0
--0
--0
--64K
11.11%-64K
Proceeds from stock option exercised by employees
--3.94M
--3.81M
--0
----
----
--0
--0
--0
----
----
Net other financing activities
8.79%-83K
--0
--0
----
----
---91K
--0
---27K
----
----
Cash from discontinued financing activities
Financing cash flow
153,797.80%139.87M
--97.85M
--0
--42.09M
-18.75%-76K
-1.11%-91K
--0
-50.00%-27K
--0
11.11%-64K
Net cash flow
Beginning cash position
62.15%40.33M
52.12%52.5M
160.13%90.33M
143.23%52.98M
62.15%40.33M
-31.80%24.87M
-28.46%34.51M
0.47%34.72M
-16.81%21.78M
-31.80%24.87M
Current changes in cash
697.02%123.21M
1,808.58%111.04M
-17,911.43%-37.82M
188.57%37.35M
508.96%12.65M
233.30%15.46M
124.89%5.82M
-101.53%-210K
54.47%12.94M
69.95%-3.09M
End cash Position
305.50%163.54M
305.50%163.54M
52.12%52.5M
160.13%90.33M
143.23%52.98M
62.15%40.33M
62.15%40.33M
-28.46%34.51M
0.47%34.72M
-16.81%21.78M
Free cash flow
4.60%-35.87M
-6.99%-9.31M
-27.95%-8.44M
17.73%-7.74M
19.51%-10.38M
-41.48%-37.6M
-72.89%-8.7M
-21.51%-6.6M
-82.97%-9.41M
-17.52%-12.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 4.66%-35.81M-6.99%-9.31M-28.55%-8.43M18.29%-7.69M19.47%-10.38M-41.95%-37.56M-73.10%-8.7M-22.70%-6.56M-83.64%-9.41M-17.58%-12.89M
Net income from continuing operations -10.33%-44.6M-24.93%-12.77M-13.78%-11.22M15.77%-9.51M-22.66%-11.1M38.71%-40.42M73.77%-10.22M-28.20%-9.86M-32.26%-11.29M15.90%-9.05M
Depreciation and amortization -2.64%332K-23.36%82K6.33%84K6.41%83K7.79%83K37.50%341K42.67%107K23.44%79K47.17%78K37.50%77K
Other non cash items -0.39%1.01M-14.24%259K807.14%254K-26.90%250K-27.86%246K-25.84%1.01M-11.70%302K-91.79%28K0.00%342K0.00%341K
Change In working capital 196.81%4.01M1,199.12%2.5M-1.34%1.85M2,394.74%436K86.63%-771K-867.90%-4.14M-109.19%-227K717.47%1.87M-102.59%-19K-99.34%-5.77M
-Change in prepaid assets 199.76%1.26M163.00%1.72M-860.00%-950K-98.61%57K107.08%435K-577.36%-1.27M-6.30%654K-55.83%125K772.55%4.1M-418.13%-6.15M
-Change in payables and accrued expense 1,082.80%4.06M358.16%1.66M61.56%2.95M107.50%112K-201.68%-665K-75.13%343K-131.96%-643K808.46%1.83M-341.75%-1.49M145.04%654K
-Change in other current assets 85.74%-328K-20,966.67%-632K258.33%95K122.22%510K-618.97%-301K-1,136.04%-2.3M-103.30%-3K-177.92%-60K-9,462.50%-2.3M-25.64%58K
-Change in other current liabilities -7.31%-984K-7.66%-253K-1,205.26%-248K26.59%-243K27.71%-240K30.90%-917K29.22%-235K94.28%-19K0.00%-331K0.00%-332K
Cash from discontinued investing activities
Operating cash flow 4.66%-35.81M-6.99%-9.31M-28.55%-8.43M18.29%-7.69M19.47%-10.38M-41.95%-37.56M-73.10%-8.7M-22.70%-6.56M-83.64%-9.41M-17.58%-12.89M
Investing cash flow
Cash flow from continuing investing activities -63.93%19.16M54.98%22.5M-560.80%-29.39M-86.82%2.95M134.28%23.1M255.23%53.11M179.14%14.52M-66.52%6.38M65.54%22.35M1,223.49%9.86M
Net PPE purchase and sale -40.00%-63K--078.38%-8K-2,650.00%-55K--062.50%-45K--055.42%-37K90.00%-2K45.45%-6K
Net investment purchase and sale -63.84%19.22M54.98%22.5M-558.02%-29.38M-86.58%3M134.14%23.1M252.70%53.15M179.16%14.52M-66.47%6.42M65.31%22.35M1,205.03%9.87M
Cash from discontinued investing activities
Investing cash flow -63.93%19.16M54.98%22.5M-560.80%-29.39M-86.82%2.95M134.28%23.1M255.23%53.11M179.14%14.52M-66.52%6.38M65.54%22.35M1,223.49%9.86M
Financing cash flow
Cash flow from continuing financing activities 153,797.80%139.87M97.85M042.09M-18.75%-76K-1.11%-91K0-50.00%-27K011.11%-64K
Net common stock issuance --136.01M--94.04M--065,587.50%42.04M-18.75%-76K--0--0--0--64K11.11%-64K
Proceeds from stock option exercised by employees --3.94M--3.81M--0----------0--0--0--------
Net other financing activities 8.79%-83K--0--0-----------91K--0---27K--------
Cash from discontinued financing activities
Financing cash flow 153,797.80%139.87M--97.85M--0--42.09M-18.75%-76K-1.11%-91K--0-50.00%-27K--011.11%-64K
Net cash flow
Beginning cash position 62.15%40.33M52.12%52.5M160.13%90.33M143.23%52.98M62.15%40.33M-31.80%24.87M-28.46%34.51M0.47%34.72M-16.81%21.78M-31.80%24.87M
Current changes in cash 697.02%123.21M1,808.58%111.04M-17,911.43%-37.82M188.57%37.35M508.96%12.65M233.30%15.46M124.89%5.82M-101.53%-210K54.47%12.94M69.95%-3.09M
End cash Position 305.50%163.54M305.50%163.54M52.12%52.5M160.13%90.33M143.23%52.98M62.15%40.33M62.15%40.33M-28.46%34.51M0.47%34.72M-16.81%21.78M
Free cash flow 4.60%-35.87M-6.99%-9.31M-27.95%-8.44M17.73%-7.74M19.51%-10.38M-41.48%-37.6M-72.89%-8.7M-21.51%-6.6M-82.97%-9.41M-17.52%-12.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More